Patent wars: what’s behind Amgen’s possible win over Sanofi at the US Supreme Court
Pharmaceutical Technology
FEBRUARY 22, 2023
Both drugs are monoclonal antibodies that inhibit the protein PCSK9. Both drugs come with a high price tag. Amgen’s Repatha was greenlit a month later. This lowers the levels of low-density lipoprotein (LDL) cholesterol, which is colloquially known as the “bad” cholesterol.
262 
Let's personalize your content